Clinical TrialsSearch results
Number of results: 690
Recruiting
- Watchman ICE
- non-valvular atrial fibrillation
- Kusano Kengo
- 2023-03-27
Other
- A phase I study of chemoradiotherapy with use of involved-field conformal radiotherapy and accelerated hyperfractionation for stage III non-small cell lung cancer
- Non-small-cell lung cancer
- West Japan Oncology Group
- 2008-07-08
Other
- A phase II study of Iressa and vinorelbine/gemcitabine in chemo-naive elderly patients with advanced non-small-cell lung cancer screened for EGFR mutation status.
- Non-small-cell lung cancer
- IVAN Investigators
- 2006-06-23
Other
- Randomiazed controlled trial comparing docetaxel-cisplatin combination with docetaxel alone in elderly patients with advanced non-small-cell lung cancer(JCOG0207)
- non-small-cell lung cancer
- Japan Clinical Oncology Group(JCOG)
- 2005-09-09
Other
- Randomiazed controlled trial comparing docetaxel-cisplatin combination with docetaxel alone in elderly patients with advanced non-small-cell lung cancer(JCOG0803/WJOG4307L)
- non-small-cell lung cancer
- Japan Clinical Oncology Group(JCOG)
- 2008-10-10
Recruiting
- Subpleural lymphatic flow in lung cancer
- Non-small-cell lung cancer
- Tane Shinya
- 2024-02-22
Other
- Docetaxel in combination with either cisplatin (DC) or gemcitabine (DG) in unresectable non-small sell lung carcinoma (NSCLC)
- Non-small sell lung carcinoma (NSCLC)
- The Tokyo cooperative oncology group
- 2006-01-23
Other
- A combination phase II study of gemcitabine with carboplatin for previously untreated elderly non-small cell lung cancer.
- Non-small cell lung cancer
- Institute of Biomedical Research and Innovation
- 2005-09-08
Other
- A combination phase II study of paclitaxel and gemcitabine for recurrent or relapsed non-small cell lung cancer previously treated with platinum or docetaxel-based regimen
- non-small cell lung cancer
- West Japan Oncology Group
- 2005-09-13
Other
- Docetaxel(D) versus docetaxel plus gemcitabine(DG) for second-line treatment of non-small cell lung cancer (NSCLC) : Results of a JCOG randomized trial (JCOG0104)
- Non-small cell Lung Cancer
- Japan Clinical Oncology Group(JCOG)
- 2005-07-22